Literature DB >> 16547786

Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease.

Marc Miravitlles1, Miriam Calle, Francisco Alvarez-Gutierrez, Elena Gobartt, Francisco López, Antonio Martín.   

Abstract

Impaired health status may be a risk factor for frequent exacerbations and hospital admission and, in turn, exacerbations and admissions may further impair the health status of patients with COPD. We have investigated the variables associated with frequent exacerbations (3 or more per year) and admission, with particular interest in health status, in a cohort of ambulatory patients with moderate to severe COPD attended by chest physicians in Spain. A total of 227 investigators included 1057 patients with a mean predicted FEV1 of 41.8%. The mean total score on the St. George's Respiratory Questionnaire (SGRQ) was 47.9 units, and 300 patients (28.4%) had 3 or more exacerbations the previous year and 344 (32.6%) were admitted at least once during the same period. In multivariate analysis only the SGRQ total score was significantly associated with both frequent exacerbations (OR = 1.04; 95% CI = 1.01-2.12; p<0.0001) and admission (OR = 1.01; 95% CI = 1.00-1.02; p = 0.0008). Other variables significantly associated with frequent exacerbations were chronic mucus hypersecretion, increased baseline dyspnea, comorbidity, GOLD stage IV and treatment with inhaled corticosteroids. Variables associated with admission were lower educational level, increased number of exacerbations, use of long-term oxygen therapy and use of short acting beta-2 agonists. An impaired health status is associated with an increased number of exacerbations and with admission to hospital in the previous year. These results, together with previous studies, confirm that impairment in health status in COPD is both a marker of risk for, and a consequence of, frequent exacerbations and admissions.

Entities:  

Mesh:

Year:  2006        PMID: 16547786     DOI: 10.1007/s11136-005-3215-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  30 in total

1.  Impact of preventing exacerbations on deterioration of health status in COPD.

Authors:  S Spencer; P M A Calverley; P S Burge; P W Jones
Journal:  Eur Respir J       Date:  2004-05       Impact factor: 16.671

2.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; E A Paul; J C Bestall; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

3.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.

Authors:  P Lange; J Nyboe; M Appleyard; G Jensen; P Schnohr
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

4.  Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.

Authors:  M Miravitlles; T Guerrero; C Mayordomo; L Sánchez-Agudo; F Nicolau; J L Segú
Journal:  Respiration       Date:  2000       Impact factor: 3.580

5.  Pharmacoeconomic evaluation of COPD.

Authors:  D E Hilleman; N Dewan; M Malesker; M Friedman
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

6.  Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.

Authors:  M Miravitlles; C Mayordomo; M Artés; L Sánchez-Agudo; F Nicolau; J L Segú
Journal:  Respir Med       Date:  1999-03       Impact factor: 3.415

7.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Authors:  S Spencer; P W Jones
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Authors:  V Brusasco; R Hodder; M Miravitlles; L Korducki; L Towse; S Kesten
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

9.  Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.

Authors:  Tom M A Wilkinson; Gavin C Donaldson; John R Hurst; Terence A R Seemungal; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2004-02-27       Impact factor: 21.405

10.  Chronic mucus hypersecretion in COPD and death from pulmonary infection.

Authors:  E Prescott; P Lange; J Vestbo
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

View more
  21 in total

1.  Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.

Authors:  E L Hardaker; M S Freeman; N Dale; P Bahra; F Raza; K H Banner; C Poll
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Effectiveness of temporary positive expiratory pressure (T-PEP) at home and at hospital in patients with severe chronic obstructive pulmonary disease.

Authors:  Valentina Mascardi; Bruna Grecchi; Cornelius Barlascini; Paolo Banfi; Antonello Nicolini
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  Difficulties in differential diagnosis of COPD and asthma in primary care.

Authors:  Marc Miravitlles; Isabel Andreu; Yolanda Romero; Salvador Sitjar; Andreu Altés; Esther Anton
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

4.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

5.  Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease?

Authors:  R Perez-Padilla; W M Vollmer; J C Vázquez-García; P L Enright; A M B Menezes; A S Buist
Journal:  Int J Tuberc Lung Dis       Date:  2009-03       Impact factor: 2.373

6.  Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease.

Authors:  Cristina Esquinas; Maria A Ramon; Alexa Nuñez; Jesús Molina; José A Quintano; Miguel Roman-Rodríguez; Karlos Naberan; Carl Llor; Carlos Roncero; Marc Miravitlles; Miriam Barrecheguren
Journal:  Qual Life Res       Date:  2019-10-31       Impact factor: 4.147

7.  Depression in individuals with chronic obstructive pulmonary disease and their informal caregivers.

Authors:  Hoda Badr; Alex D Federman; Michael Wolf; Tracey A Revenson; Juan P Wisnivesky
Journal:  Aging Ment Health       Date:  2016-05-20       Impact factor: 3.658

8.  Exacerbation frequency and course of COPD.

Authors:  David M G Halpin; Marc Decramer; Bartolome Celli; Steven Kesten; Dacheng Liu; Donald P Tashkin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-21

9.  Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish Study.

Authors:  Antonio Martín; José M Rodríguez-González Moro; José L Izquierdo; Elena Gobartt; Pilar de Lucas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review.

Authors:  Katayoon Bahadori; J Mark FitzGerald
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.